DiagnosticsCommercial
ALBII
A self-test kit that screens urine for microalbuminuria, with results in 10 minutes, making it quick and easy to screen for early kidney disease risk.
Seeking
02
The need
Early kidney disease is often missed because screening requires a hospital visit or a laboratory test.
03
The innovation
Quick self-screening for microalbuminuria with high specificity, easy to use at home.
04
Development stage
- Explore
- Develop
- Validate
- Market-ready
- Commercial
Has regulatory approval and is manufactured under ISO 13485.
05
Evidence and results
Sensitivity 87.21%, specificity 97.64%, accuracy 95.81%; results in 10 minutes.
06
Next milestone
Expanding access and distribution, and integration into health benefit programs.
Team
- ศ.นพ. ณัฐชัย ศรีสวัสดิ์